REVIVO BioSystems is an innovative and service-oriented startup founded by a team of engineers and biologists, with many years of experience in biomedical engineering, cell cultures, microfluidics and tissue engineering.
Aiming to become the Asian and global leading provider of enabling technologies and services for ex vivo and in vitro testing of chemicals, ingredients, cosmetic formulations and therapeutics, our goal is to deliver products and services with unmatched quality, consistency, reproducibility, and ease-of-use.
Our novel testing platforms enable realistic studies and cost enhancement versus other models and traditional methods.
Dr. Bert Grobben
CBO / Co-Founder
Dr. Massimo Alberti
CEO / Founder
Prof. Sriram Gopu
Scientific Advisor / Co-Founder
Advisory Board Members
Dr. Alain Khaiat
Dr. Chris Thoen
Dr. Akira Date
REVIVO BioSystems is a Singapore Headquartered spin-off from A*STAR. that has it's genesis in a 2014 Skin-on-Chip research program.
Our founding team invented and developed REVIVO's platform of explants-on-chip and skin-on-chip technology at the Singapore Institute of Manufacturing Technology and the Institute of Medical Biology in A*STAR.